| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910811798703321 |
|
|
Titolo |
Tumor board review : guideline and case reviews in oncology / / Robert F. Todd [and four others], editors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, New York : , : Demos Medical, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[Second edition.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (449 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Tumors - Diagnosis |
Tumors - Thermotherapy |
Cancer |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Title; Copyright; Contents; Contributors; Preface to the Second Edition; Preface to the First Edition; Share Tumor Board Review: Guideline and Case Reviews in Oncology, Second Edition; Chapter 1: Head and Neck Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Overview of Staging; Site-Specific Staging for SCCHN; Case Summaries; Locoregionally Advanced Disease; Evidence-Based Case Discussion; Recurrent/Metastatic SCCHN; Evidence-Based Case Discussion; Summary; Review Questions; References; Chapter 2: Thyroid Cancer |
Epidemiology, Risk Factors, Natural History, and PathologyDifferentiated Thyroid Carcinoma; Staging; Case Summaries; Early-Stage Papillary Thyroid Cancer: Stage I; Evidence-Based Case Discussion; Differentiated Follicular Thyroid Cancer: Late-Stage Follicular Thyroid Cancer; Evidence-Based Case Discussion; Medullary Thyroid Cancer; Evidence-Based Case Discussion; Anaplastic Thyroid Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 3: Non-Small-Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Early-Stage NSCLC |
Evidence-Based Case DiscussionSurgery and Adjuvant Chemotherapy in Early-Stage NSCLC; Regional (Stage III) NSCLC; Evidence-Based Case |
|
|
|
|
|
|
|
|
|
|
|
Discussion; Metastatic NSCLC, Case 1; Evidence-Based Case Discussion; Metastatic NSCLC, Case 2; Evidence-Based Case Discussion; Recurrent NSCLC; Evidence-Based Case Discussion; Review Questions; References; Chapter 4: Small Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; LS-SCLC: Combined Modality Therapy; Evidence-Based Case Discussion; ES-SCLC: Systemic Palliative Therapy; Evidence-Based Case Discussion |
Review QuestionsReferences; Chapter 5: Breast Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Ductal Carcinoma In Situ; Early-Stage ER+ Breast Cancer; Early-Stage ER+ Breast Cancer, Stage I or II; Early-Stage TNBC; Locally Advanced HER2+ Breast Cancer; Metastatic Breast Cancer; A Special Note on Breast Cancer in Pregnancy; Review Questions; References; Chapter 6: Esophageal Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Locally Advanced Resectable Esophageal Cancer; Evidence-Based Case Discussion |
Locally Advanced Unresectable Esophageal CancerEvidence-Based Case Discussion; Metastatic Esophageal Cancer; Evidence-Based Case Discussion; Acknowledgment; Review Questions; References; Chapter 7: Gastric Cancer; Epidemiology, Natural History, Risk Factors, and Pathology; Staging; Case Summaries; Resectable Gastric Cancer; Evidence-Based Case Discussion; Locally Advanced Unresectable and Metastatic Gastric Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 8: Pancreatic Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries |
Resectable Pancreatic Adenocarcinoma |
|
|
|
|
|
|
Sommario/riassunto |
|
p> Praise for the First Edition:. ""As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information...by the time the book is [published]...it is outdated."" [Tumor Board Review] is fresh and just out of the oven...I haven't seen any book in oncology like this so far...I think my investment in this book was wise and worth it."" - Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center. Culling the knowledge and expertise of res |
|
|
|
|
|
|
|
| |